September 13, 2022 – The U.S. Preventive Services Task Force released today a final recommendation statement on screening for prediabetes and type 2 diabetes in children and adolescents. The Task Force concluded that more research is needed to recommend for or against screening children and teens without signs or symptoms. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the September 13, 2022, online issue of JAMA.
